Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies

Abstract

A sequence of novel quinoline-1,3,4-oxadiazole hybrids has been synthesized and evaluated for their in vitro anti-proliferative and antimicrobial activities.